IONS vs UNMA · rev $514.0M vs P/E 4.6, $5.35B cap
Ionis Pharmaceuticals Inc (IONS) versus Unum Group 6.250% JR NT58 (UNMA) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Unum Group 6.250% JR NT58 (UNMA) common stock listed on NYSE.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
UNMA does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. UNMA currently screens at market cap $5.35B and trailing P/E 4.6.
Not investment advice. Open the IONS and UNMA stock pages for the full models.
Not investment advice.